Table of Content - India Immuno Oncology Drugs Market

Immuno-Oncology also known as cancer immunotherapy, is a form of cancer treatment that utilizes immune system of the body to manage, prevent, and destroy cancer. Immuno-oncologists are growing and becoming a part of cancer care group by rapidly increasing the cancer care area. The researchers did study on how to attack cancer by the immune system. Some of them work in labs on creating new treatments and some of them interact between the immune system and cancer cells.

India immuno-oncology drugs market is estimated to be valued at US$ 265 Mn in 2021 and is expected to increase to US$ 550 Mn by 2028, exhibiting a CAGR of 13.1% over the forecast period.

Market Dynamics

The rising incidence of cancer, introduction of novel immuno-oncology therapies with lesser side effects, increasing government engagement to increase cancer diagnosis, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the Indian immuno-oncology drugs market over the forecast period.

According to the National Cancer Registry Programme (NCRP), India, one woman dies of cervical cancer every 8 minutes in India. For every 2 women newly diagnosed with breast cancer, one woman dies of it in India. Furthermore, as many people die every day due to tobacco-related cancer diseases in India. Tobacco (smoked and smokeless) use accounted for around 317,928 deaths in men and women, in 2018.

Moreover, The WHO also suggested that people with low and middle income countries should have necessary data for cancer policies because of lack of awareness for treatment availability.

Key features of the study:

This report provides an in-depth analysis of the India immuno-oncology drugs market provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the India immuno-oncology drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Amgen Inc., F. Hoffmann-La Roche AG., Intas Pharmaceuticals Ltd., AstraZeneca plc, Mylan N.V., Dr. Reddy's Laboratories, Bristol - Myers Squibb, Merck & Co., Inc., BIOCAD-Biotechnology company, Reliance Life Sciences, Biocon Limited, and Hetero Drugs Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The India immuno-oncology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India immuno-oncology drugs market

Detailed Segmentation:

India Immuno-Oncology Drugs Market, Drug Type:
- Immune Checkpoint Inhibitors
  - Nivolumab
  - Atezolimumab
  - Pembrolizumab
  - Durvalumab
- Monoclonal Antibodies
  - Rituximab
  - Trastazumab
  - Bevacizumab
  - Nimotuzumab
  - Pertuzumab
  - Ado-Trastuzumab Emtansine
- Cancer Vaccines
  - Gardasil
  - Cervarix
India Immuno-Oncology Drugs Market, Cancer Type:
- Lung cancer
- Blood cancer
- Breast cancer
- Ovarian cancer
- Cervical cancer
- Colorectal cancer
- Stomach cancer
- Head & Neck cancer
- Others
India Immuno-Oncology Drugs Market, Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Company Profiles:
- Amgen, Inc. *
  - Company highlights
  - Product Portfolio
  - Key Highlights
  - Financial performance
  - Strategies
- Hoffmann-La Roche AG.
- Intas Pharmaceuticals Ltd.
- AstraZeneca plc
- Mylan N.V.
- Reddy's Laboratories
- Bristol - Myers Squibb
- Merck & Co., Inc.
- BIOCAD-Biotechnology company
- Reliance Life Sciences
- Biocon Limited
- Hetero Drugs Limited

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Cancer Type
  - Market Snippet, By Distribution Channels
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Cancer Analysis
- Cancer Epidemiology
- Key Challenges
- Similar Biologics Approved And Marketed In India
- Patient Population
- Key Developments
- Regulatory Scenario
- Adoptive T Cell Therapies
- PEST Analysis
- Porter’s Five Forces Analysis
India Immuno-Oncology Drugs Market– Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact of COVID-19 on Healthcare market
- COVID-19 Epidemiology
India Immuno-Oncology Drugs Market, By Drug Type, 2021 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Immune Checkpoint Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    - Nivolumab
    - Atezolimumab
    - Pembrolizumab
    - Durvalumab
- Monoclonal Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    - Rituximab
    - Trastazumab
    - Bevacizumab
    - Nimotuzumab
    - Pertuzumab
    - Ado-Trastuzumab Emtansine
- Cancer Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    - Gardasil
    - Cervarix
India Immuno-Oncology Drugs Market, By Cancer Type, 2021 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Lung cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Blood cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Breast cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ovarian cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Cervical cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Colorectal cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Stomach cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Head & Neck cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
India Immuno-Oncology Drugs Market, By Distribution Channel, 2021 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Amgen, Inc.
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - F. Hoffmann-La Roche AG
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Intas Pharmaceuticals Ltd.
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - AstraZeneca plc
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Mylan N.V.
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Dr. Reddy's Laboratories
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Bristol - Myers Squibb
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Merck & Co., Inc.
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - BIOCAD-Biotechnology Company
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Reliance Life Sciences
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Biocon Limited
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
  - Hetero Drugs Limited
    - Company highlights
    - Product Portfolio
    - Key Highlights
    - Financial performance
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 5 market data tables and 20 figures on "India Immuno-Oncology Drugs Market” – India forecast to 2028

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount